# The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Surgical Outcomes and NHS Cost Savings.

> **NCT07483502** · NA · NOT_YET_RECRUITING · sponsor: **Hull University Teaching Hospitals NHS Trust** · enrollment: 80 (estimated)

## Conditions studied

- Cardiovascular Diseases (CVD)
- Cardiovascular Surgery

## Interventions

- **DIETARY_SUPPLEMENT:** 5g of prebiotic fibre and 300mg of magnesium (WellBiome)
- **DIETARY_SUPPLEMENT:** 5g of maltodextrin

## Key facts

- **NCT ID:** NCT07483502
- **Lead sponsor:** Hull University Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2026-10-28
- **Final completion:** 2026-12-18
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07483502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07483502, "The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Surgical Outcomes and NHS Cost Savings.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07483502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*